Judge Throws Out $140 Million Verdict in AbbVie AndroGel Case, Orders New Trial

Drug Industry Daily
A A
An Illinois federal judge canned a $140 million verdict against AbbVie and ordered a new trial involving its testosterone replacement therapy, AndroGel, after ruling the jury’s findings were contradictory.

To View This Article:

Login

Subscribe To Drug Industry Daily